Clinical Trial Update: Antinociceptive Modalities on Ischemia Reperfusion Injury

View source ↗

Summary

The clinical trial NCT01932918 evaluating antinociceptive modalities for ischemia-reperfusion injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Lung Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: End Stage Liver Disease, Lung Cancer | Status: COMPLETED